Europe Oligonucleotides Synthesis Market – Industry Trends and Forecast to 2026

  • Healthcare IT
  • Published Report
  • Aug 2019
  • Europe
  • 350 Pages
  • No of Tables: 166
  • No of Figures: 22

Europe Oligonucleotides Synthesis Market By Product Type (DNA Oligonucleotides, RNA Oligonucleotides), Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos), Consumables (Instruments, Kits & Reagents, Others), Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis), Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others), End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others), Country (Germany,  U.K., France, Switzerland, Italy, Belgium, Denmark, Sweden, Spain, Netherlands, Russia, Turkey, Rest of Europe) – Industry Trends and Forecast to 2026

Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.

The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures. Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.

The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.

The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.

Europe oligonucleotides synthesis market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: Europe Oligonucleotides Synthesis Market

Europe oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.

  • On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.
  • On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.
  • On the basis of consumables, the market is segmented into instruments, kits & reagents and others.
  • On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.
  • On the basis of distribution channel the market is segmented into multi-level marketing, large retail, small retail, health and beauty stores, online and others.
  • On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.
  • On the basis of end user, the market is segmented into bio-pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals and others.

Competitive Analysis: Europe Oligonucleotides Synthesis Market

Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.

Recent Development:

  • In December 2018, Biolytic Lab Performance Inc. introduced the Dr. Oligo 192c which is designed for the synthesis of bio molecules. The redesign of the Dr. Oligo 48 enhances the process output and helping the researchers in the cost reduction in synthesis process. The new introduction of the instrument will expand the business of the company globally and helps in offering the product overseas.
  • In March 2015, Biolytic Lab Performance Inc. introduced the Dr. Oligo 48 which is a type of rotor synthesizer incorporated with the advanced performance speed, quality of synthesis and cost reduction in process. The product is launched globally and the introduction of the new product enhances the company’s product offering and help to enhance the business in synthesizers market.

Research Methodology: Europe Oligonucleotides Synthesis Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.


SKU-

TABLE 1 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 2 EUROPE DNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 3 EUROPE RNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 5 EUROPE OLIGONUCLEOTIDE-BASED DRUGS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 EUROPE PRIMERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 EUROPE PROBES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 EUROPE INTERMEDIATE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 EUROPE LARGE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 EUROPE LINKERS & ADAPTORS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 EUROPE ARRAY-BASED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 13 EUROPE INSTRUMENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 EUROPE KITS & REAGENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 EUROPE OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 17 EUROPE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 EUROPE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 19 EUROPE PREDESIGNED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 EUROPE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 22 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 23 EUROPE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 EUROPE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 25 EUROPE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 27 EUROPE DIAGNOSTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 EUROPE OTHERS APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 EUROPE BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN OLIGO NUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE ACADEMIC & RESEARCH INSTITUTES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 EUROPE HOSPITALS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 36 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 37 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 38 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 39 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 40 EUROPE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 41 EUROPE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 42 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 EUROPE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 EUROPE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 46 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 47 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 48 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 49 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 50 GERMANY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 51 GERMANY OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 52 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 53 GERMANY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 54 GERMANY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 56 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 57 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 58 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 59 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 60 U.K. CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 61 U.K. OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 62 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 63 U.K. RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 64 U.K. THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 65 U.K. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 66 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 67 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 68 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 69 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 70 FRANCE CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 71 FRANCE OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 72 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 FRANCE RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 74 FRANCE THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 75 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 76 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 77 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 78 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 79 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 80 SWITZERLAND CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 81 SWITZERLAND OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 82 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 83 SWITZERLAND RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 84 SWITZERLAND THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 85 SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 86 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 87 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 88 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 89 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 90 ITALY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 91 ITALY OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MAR KET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 92 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 93 ITALY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 94 ITALY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 95 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 96 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 97 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 98 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 99 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 100 BELGIUM CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 101 BELGIUM OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 102 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 103 BELGIUM RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 104 BELGIUM THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 105 BELGIUM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 106 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 107 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 108 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 109 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 110 DENMARK CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 111 DENMARK OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 112 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 113 DENMARK RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 114 DENMARK THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 115 DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 116 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 117 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 118 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 119 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 120 SWEDEN CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 121 SWEDEN OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 122 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 123 SWEDEN RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 124 SWEDEN THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 125 SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 126 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 127 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 128 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 129 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 130 SPAIN CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 131 SPAIN OLIGO SYNTHESIS IN OLI GONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 132 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 133 SPAIN RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 134 SPAIN THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 135 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 136 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 137 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 138 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 139 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SER VICE TYPE, 2017-2026 (USD MILLION)

TABLE 140 NETHERLANDS CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 141 NETHERLANDS OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 142 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 143 NETHERLANDS RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 144 NETHERLANDS THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 145 NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 146 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 147 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 148 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 149 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 150 RUSSIA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 151 RUSSIA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 152 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 153 RUSSIA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 154 RUSSIA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 155 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 156 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 157 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 158 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)

TABLE 159 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 160 TURKEY CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 161 TURKEY OLIGO SYNTH ESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 162 TURKEY OLIGONUCLEO TIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 163 TURKEY RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 164 TURKEY THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 165 TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 166 REST OF EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions